Jazz Pharmaceuticals plc (JAZZ) earnings: date, estimates, results and stock reactions
Over the last 12 reports the stock moved 7.1% on average (either way), rising 7 times and falling 5. EPS beat estimates 7 of 12 times; revenue 7 of 12. Close before the report date to the first close after it (two trading sessions, covering before-the-open and after-the-close reports).
| Quarter | Reported | EPS | EPS estimate | EPS surprise | Revenue | Revenue estimate | Stock move |
|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 2026-11-02 | -3.88 | -4.03 | +3.7% | 1.24B | 1.21B | +6.4% |
| Q2 FY2026 | 2026-08-03 | 5.71 | 6.18 | -7.6% | 1.21B | 1.11B | +3.5% |
| Q1 FY2026 | 2026-05-05 | 6.34 | 4.64 | +36.6% | 1.07B | 978.7M | +9.9% |
| Q4 FY2025 | 2026-02-24 | 6.64 | 6.52 | +1.8% | 1.20B | 1.17B | +13.6% |
| Q3 FY2025 | 2025-11-05 | 8.13 | 5.95 | +36.6% | 1.13B | 1.11B | -2.7% |
| Q2 FY2025 | 2025-08-05 | -8.25 | -6.12 | -34.8% | 1.05B | 1.05B | -8.8% |
| Q1 FY2025 | 2025-05-06 | 1.68 | 4.51 | -62.7% | 897.8M | 1.06B | -14.2% |
| Q4 FY2024 | 2025-02-25 | 6.60 | 5.83 | +13.2% | 1.09B | 985.0M | +5.5% |